Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory Glaucoma

F, Bezci Aygün; Mocan, Mehmet Cem; Kocabeyoğlu, Sibel; İrkeç, Murat

doi:10.4274/tjo.18559

Cited by 11 publications

(21 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Limiting the area of ablation per session to no more than 180 degrees appears to confer increased safety to the TSCPC procedure, though the procedure may need to be repeated to achieve target IOPs. 93 An intraocular procedure that has more recently been utilized in the pediatric population is ECP. 93 Using a 19-23gauge instrument, one can endoscopically visualize the ciliary body processes and treat with photocoagulation directly to the processes.…”

Section: Study Limitationsmentioning

confidence: 99%

“…93 An intraocular procedure that has more recently been utilized in the pediatric population is ECP. 93 Using a 19-23gauge instrument, one can endoscopically visualize the ciliary body processes and treat with photocoagulation directly to the processes. 94 Studies reporting results from ECP have been promising, with no sight-threatening complications of severe hypotony, intractable pain, or recalcitrant inflammation.…”

Section: Study Limitationsmentioning

confidence: 99%

See 1 more Smart Citation

Update in Genetics and Surgical Management of Primary Congenital Glaucoma

Mocan¹,

Mehta²,

Aref³

2019

tjo

Self Cite

View full text Add to dashboard Cite

Primary congenital glaucoma (PCG) continues to be an important cause of visual impairment in children despite advances in medical and surgical treatment options. The progressive and blinding nature of the disease, together with the long lifespan of the affected population, necessitates a thorough understanding of the pathophysiology of PCG and the development of long-lasting treatment options. The first part of this review discusses the genetic features and makeup of this disorder, including all currently identified genetic loci (GLC3A, GLC3B, GLC3C and GLC3D) and relevant protein targets important for trabecular and Schlemm canal dysgenesis. These target molecules primarily include CYP1B1, LTBP2, and TEK/Tie2 proteins. Their potential roles in PCG pathogenesis are discussed with the purpose of bringing the readers up to date on the molecular genetics aspect of this disorder. Special emphasis is placed on functional implications of reported genetic mutations in the setting of PCG. The second part of the review focuses on various modifications and refinements to the traditional surgical approaches performed to treat PCG, including advances in goniotomy and trabeculotomy ab externo techniques, glaucoma drainage implant surgery and cyclodiode photocoagulation techniques that ultimately provide safer surgical approaches and more effective intraocular pressure control in the 21 st century.

show abstract

Section: Study Limitationsmentioning

confidence: 99%

Section: Study Limitationsmentioning

confidence: 99%

Update in Genetics and Surgical Management of Primary Congenital Glaucoma

Mocan¹,

Mehta²,

Aref³

2019

tjo

Self Cite

View full text Add to dashboard Cite

show abstract

“…Compared with baseline, both groups showed a significant decrease in the number of medications, P < 0.01. No statistical difference was reached between groups energy, the best number and range of photocoagulation points remain inconclusive around the world [23][24][25].…”

Section: Discussionmentioning

confidence: 95%

Comparison of ultrasound cycloplasty and transscleral cyclophotocoagulation for refractory glaucoma in Chinese population

Liang

et al. 2020

BMC Ophthalmol

View full text Add to dashboard Cite

Background To compare the efficacy and safety of focused ultrasound cycloplasty (UCP) and transscleral cyclophotocoagulation (TSCP) in the treatment of refractory glaucoma in a Chinese population. Methods We retrospectively compared twenty-eight eligible patients with refractory glaucoma, who were divided into the UCP group and TSCP group. Patients in these two groups underwent a corresponding procedure from June 2018 to February 2019. The intraocular pressure (IOP), visual acuity, the number of anti-glaucoma agents used and complications were reviewed and compared between groups. Proper statistical methods were selected according to comparison models under IBM SPSS 25 software. Results After the 12-months follow-up, postoperative IOP and number of anti-glaucoma agents used in the two groups were both reduced than the baseline level, and the differences were statistically significant (P < 0.05). There were no significant differences in IOP, number of anti-glaucoma agents and the best-corrected visual acuity between the two groups at each follow-up time point (P>0.05). In terms of complications, the pain at 1 day after surgery in the UCP group was significantly milder than that in the TSCP group (P < 0.05). And there were no significant differences in other complications between the two groups (P > 0.05). Conclusions Both UCP and TSCP are safe and effective methods for the treatment of refractory glaucoma. Nevertheless, pain is less severe after UCP.

show abstract

“…Intraoperatively, the number and range of photocoagulation should be determined according to the baseline IOP of the patients and the surgeon's experience. However, the suitable laser energy, the best number and range of photocoagulation points remain inconclusive around the world [22,23,24].…”

Section: Discussionmentioning

confidence: 99%

Comparison of Ultrasound Cycloplasty and Transscleral Cyclophotocoagulation for Refractory Glaucoma in Chinese Population

Liang

et al. 2020

Preprint

View full text Add to dashboard Cite

Background To compare the efficacy and safety of focused ultrasound cycloplasty (UCP) and transscleral cyclophotocoagulation (TSCP) in the treatment of refractory glaucoma in a Chinese population. Methods We retrospective compared twenty-eight eligible patients with refractory glaucoma, who were divided into the UCP group and TSCP group. Patients in these two groups underwent a corresponding procedure from June 2018 to February 2019. The intraocular pressure (IOP), visual acuity, the number of anti-glaucoma agents used and complications were reviewed and compared between groups. Proper statistical methods were selected according to comparison models under IBM SPSS 25 software. Results After the 12-months follow-up, postoperative IOP and number of anti-glaucoma agents used in the two groups were both reduced than the baseline level, and the differences were statistically significant (P<0.05). There were no significant differences in IOP, number of anti-glaucoma agents and the best-corrected visual acuity between the two groups at each follow-up time point (P＞0.05). In terms of complications, the pain at 1 day after surgery in the UCP group was significantly milder than that in the TSCP group (P<0.05). And there were no significant differences in other complications between the two groups (P>0.05). Conclusions Both UCP and TSCP are safe and effective methods for the treatment of refractory glaucoma. Nevertheless, pain is less severe after UCP.

show abstract

Efficacy of 180° Cyclodiode Transscleral Photocoagulation for Refractory Glaucoma

Cited by 11 publications

References 14 publications

Update in Genetics and Surgical Management of Primary Congenital Glaucoma

Update in Genetics and Surgical Management of Primary Congenital Glaucoma

Comparison of ultrasound cycloplasty and transscleral cyclophotocoagulation for refractory glaucoma in Chinese population

Comparison of Ultrasound Cycloplasty and Transscleral Cyclophotocoagulation for Refractory Glaucoma in Chinese Population

Contact Info

Product

Resources

About